Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

EXELIXIS, INC. Director's Dealing 2020

Mar 7, 2020

30561_dirs_2020-03-06_5b355076-877d-4c44-9643-4aa9bf15507d.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: EXELIXIS, INC. (EXEL)
CIK: 0000939767
Period of Report: 2020-03-04

Reporting Person: MORRISSEY MICHAEL (Director, President and CEO)

Non-Derivative Transactions

Date Security Code Shares Price A/D Holdings After Ownership
2020-03-04 Common Stock M 50000 $5.51 Acquired 135985 Direct
2020-03-04 Common Stock F 32884 $19.89 Disposed 103101 Direct

Derivative Transactions

Date Security Exercise Price Code Shares A/D Expiration Underlying Ownership
2020-03-04 Option (right to buy) $5.51 M 50000 Disposed 2020-09-17 Common Stock (50000.0) Direct

Holdings (Non-Derivative)

Security Shares Ownership
Common Stock 322127 Indirect
Common Stock 17728 Indirect

Footnotes

F1: Includes 85,985 shares of Exelixis, Inc. Common Stock ("Common Stock") that will be issued to the Reporting Person upon vesting of restricted stock units.

F2: Represents a "net exercise" of an outstanding stock option. The Reporting Person received 17,116 shares of Common Stock on the net exercise of a stock option to purchase 50,000 shares of Common Stock. The Issuer withheld 32,884 shares of Common Stock underlying the stock option for payment of the exercise price and tax withholding using a stock price on March 4, 2020 of $19.89.

F3: Shares held by Michael M. Morrissey and Meghan D. Morrissey, Trustees of the Morrissey Family Living Trust dated July 21, 1994, as amended.

F4: Represents shares of Exelixis, Inc. common stock under the Exelixis, Inc. 401(k) Plan, pursuant to a plan statement dated as of March 4, 2020.

F5: The option, representing the right to purchase a total of 720,000 shares of Exelixis, Inc. common stock, became fully exercisable on September 18, 2017.